Stocks and Investing
Stocks and Investing
Wed, March 27, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Luca Issi Reiterated (BLUE) at Hold with Increased Target to $8 on, Mar 27th, 2024
Luca Issi of RBC Capital, Reiterated "bluebird bio, Inc." (BLUE) at Hold with Increased Target from $6 to $8 on, Mar 27th, 2024.
Luca has made no other calls on BLUE in the last 4 months.
There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 2 agree with Luca's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Nierengarten of "Wedbush" Maintained at Hold with Decreased Target to $1.68 on, Tuesday, March 19th, 2024
- Jeffrey Hung of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $7 on, Friday, December 8th, 2023
These are the ratings of the 3 analyists that currently disagree with Luca
- Morten Herholdt of "HSBC" Maintained at Sell with Decreased Target to $1.02 on, Tuesday, March 5th, 2024
- Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Decreased Target to $5 on, Thursday, December 21st, 2023
- Jack Allen of "Baird" Maintained at Buy with Decreased Target to $7 on, Tuesday, December 12th, 2023
Contributing Sources